vs
CubeSmart（CUBE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
CubeSmart的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$282.7M vs $207.3M），CubeSmart净利率更高（27.5% vs -62.0%，领先89.5%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 5.6%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 4.0%）
CubeSmart是一家专注于投资自助仓储设施的美国房地产投资信托，为美国第三大自助仓储运营商。截至2024年12月31日，公司在全美25个州及哥伦比亚特区共持有631座自助仓储物业，可出租总面积达4580万平方英尺。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CUBE vs RARE — 直观对比
营收规模更大
CUBE
是对方的1.4倍
$207.3M
营收增速更快
RARE
高出20.3%
5.6%
净利率更高
CUBE
高出89.5%
-62.0%
两年增速更快
RARE
近两年复合增速
4.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $282.7M | $207.3M |
| 净利润 | $77.7M | $-128.6M |
| 毛利率 | 68.7% | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 27.5% | -62.0% |
| 营收同比 | 5.6% | 25.9% |
| 净利润同比 | -23.7% | 3.5% |
| 每股收益（稀释后） | $0.35 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CUBERARE
| Q4 25 | $282.7M | $207.3M | ||
| Q3 25 | $285.1M | $159.9M | ||
| Q2 25 | $282.3M | $166.5M | ||
| Q1 25 | $273.0M | $139.3M | ||
| Q4 24 | $267.7M | $164.6M | ||
| Q3 24 | $270.9M | $139.5M | ||
| Q2 24 | $266.2M | $147.0M | ||
| Q1 24 | $261.4M | $108.8M |
净利润CUBERARE
| Q4 25 | $77.7M | $-128.6M | ||
| Q3 25 | $82.4M | $-180.4M | ||
| Q2 25 | $82.4M | $-115.0M | ||
| Q1 25 | $88.7M | $-151.1M | ||
| Q4 24 | $101.9M | $-133.2M | ||
| Q3 24 | $101.0M | $-133.5M | ||
| Q2 24 | $94.2M | $-131.6M | ||
| Q1 24 | $94.9M | $-170.7M |
毛利率CUBERARE
| Q4 25 | 68.7% | — | ||
| Q3 25 | 68.1% | — | ||
| Q2 25 | 68.5% | — | ||
| Q1 25 | 69.6% | — | ||
| Q4 24 | 71.7% | — | ||
| Q3 24 | 69.8% | — | ||
| Q2 24 | 68.8% | — | ||
| Q1 24 | 70.5% | — |
营业利润率CUBERARE
| Q4 25 | — | -54.7% | ||
| Q3 25 | — | -106.9% | ||
| Q2 25 | — | -64.8% | ||
| Q1 25 | — | -102.6% | ||
| Q4 24 | — | -74.3% | ||
| Q3 24 | — | -94.6% | ||
| Q2 24 | — | -79.1% | ||
| Q1 24 | — | -151.9% |
净利率CUBERARE
| Q4 25 | 27.5% | -62.0% | ||
| Q3 25 | 28.9% | -112.8% | ||
| Q2 25 | 29.2% | -69.0% | ||
| Q1 25 | 32.5% | -108.5% | ||
| Q4 24 | 38.1% | -80.9% | ||
| Q3 24 | 37.3% | -95.7% | ||
| Q2 24 | 35.4% | -89.5% | ||
| Q1 24 | 36.3% | -156.8% |
每股收益（稀释后）CUBERARE
| Q4 25 | $0.35 | $-1.28 | ||
| Q3 25 | $0.36 | $-1.81 | ||
| Q2 25 | $0.36 | $-1.17 | ||
| Q1 25 | $0.39 | $-1.57 | ||
| Q4 24 | $0.45 | $-1.34 | ||
| Q3 24 | $0.44 | $-1.40 | ||
| Q2 24 | $0.41 | $-1.52 | ||
| Q1 24 | $0.42 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.8M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $-80.0M |
| 总资产 | $6.6B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CUBERARE
| Q4 25 | $5.8M | $421.0M | ||
| Q3 25 | $108.4M | $202.5M | ||
| Q2 25 | $8.7M | $176.3M | ||
| Q1 25 | $10.8M | $127.1M | ||
| Q4 24 | $71.6M | $174.0M | ||
| Q3 24 | $43.5M | $150.6M | ||
| Q2 24 | $5.7M | $480.7M | ||
| Q1 24 | $5.6M | $112.3M |
股东权益CUBERARE
| Q4 25 | $2.7B | $-80.0M | ||
| Q3 25 | $2.8B | $9.2M | ||
| Q2 25 | $2.8B | $151.3M | ||
| Q1 25 | $2.8B | $144.2M | ||
| Q4 24 | $2.9B | $255.0M | ||
| Q3 24 | $2.8B | $346.8M | ||
| Q2 24 | $2.8B | $432.4M | ||
| Q1 24 | $2.8B | $140.3M |
总资产CUBERARE
| Q4 25 | $6.6B | $1.5B | ||
| Q3 25 | $6.8B | $1.2B | ||
| Q2 25 | $6.7B | $1.3B | ||
| Q1 25 | $6.7B | $1.3B | ||
| Q4 24 | $6.4B | $1.5B | ||
| Q3 24 | $6.2B | $1.5B | ||
| Q2 24 | $6.2B | $1.6B | ||
| Q1 24 | $6.2B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $608.5M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 7.83× | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流CUBERARE
| Q4 25 | $608.5M | $-99.8M | ||
| Q3 25 | $168.2M | $-91.4M | ||
| Q2 25 | $157.5M | $-108.3M | ||
| Q1 25 | $146.3M | $-166.5M | ||
| Q4 24 | $631.1M | $-79.3M | ||
| Q3 24 | $145.4M | $-67.0M | ||
| Q2 24 | $170.9M | $-77.0M | ||
| Q1 24 | $150.2M | $-190.7M |
自由现金流CUBERARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
自由现金流率CUBERARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
资本支出强度CUBERARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
现金转化率CUBERARE
| Q4 25 | 7.83× | — | ||
| Q3 25 | 2.04× | — | ||
| Q2 25 | 1.91× | — | ||
| Q1 25 | 1.65× | — | ||
| Q4 24 | 6.19× | — | ||
| Q3 24 | 1.44× | — | ||
| Q2 24 | 1.81× | — | ||
| Q1 24 | 1.58× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CUBE
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
